nevirapine extended release nevirapine tablet
1 INDICATIONS AND USAGE Nevirapine extended-release tablets are indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus (HIV-1) infection in adults and pediatric patients 6 years of age or older with a body surface area (BSA) of 1.17 m 2 or greater [see Clinical Studies ( 14.1 , 14.2 )] . Limitations of Use: Based on serious and life-threatening hepatotoxicity observed in controlled and uncontrolled trials, nevirapine extended-release tablets are not recommended to be initiated, unless the benefit outweighs the risk, in: adult females with CD4 + cell counts greater than 250 cells/mm 3 or adult males with CD4 + cell counts greater than 400 cells/mm 3 [ see Warnings and Precautions ( 5.1 )]. Nevirapine extended-release tablets are an NNRTI indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus (HIV-1) infection in adults and pediatric patients 6 years of age or older with a BSA of 1.17 m 2 or greater. ( 1 ) Limitations of Use: Based on serious and life-threatening hepatotoxicity observed in controlled and uncontrolled trials, nevirapine extended-release tablets are not recommended to be initiated, unless the benefit outweighs the risk, in: adult females with CD4 + cell counts greater than 250 cells/mm 3 adult males with CD4 + cell counts greater than 400 cells/mm 3 ( 1 , 5.1 )
alvogen inc.
ROUND WHITE A9
Related Pills
24 HR Nevirapine 400 MG Extended Release Oral Tablet
alvogen inc.
norgestimate and ethinyl estradiol kit
glenmark pharmaceuticals inc., usa
clopidogrel 75 MG Oral Tablet
Amneal Pharmaceuticals LLC
amlodipine besylate tablet
mylan pharmaceuticals inc.
Rosuvastatin calcium 40 MG Oral Tablet
Amneal Pharmaceuticals NY LLC
Amlodipine 10 MG atorvastatin 20 MG Oral Tablet
Mylan Pharmaceuticals Inc.
Acetaminophen 500 MG Oral Tablet
SuperValu Inc.
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING Nevirapine Extended-Release Tablets, 400 mg, are capsule-shaped, white to off white tablets, "ALV 317" debossed on one side, blank on the other side. Nevirapine Extended-Release Tablets, 400 mg, are supplied in bottles of 30 (NDC 47781-317-30). Storage Store at 25°C (77°F); excursions permitted to 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature]. Store in a safe place out of the reach of children.
More pills like ROUND A9